This measure assesses completion for 2 doses of HepA at 18 months. The evaluation timeframe should be extended to 24 months to allow true administration scheduling of these vaccines. This also will align with the Kindergarten survey assessment for 2 dose HepA
Copied from AART-2007
This measure assesses completion for 2 doses of HepA at 18 months. The evaluation timeframe should be extended to 24 months to allow true administration scheduling of these vaccines. This also will align with the Kindergarten survey assessment for 2 dose HepA